Intestinal Failure Clinical Trial
Official title:
Essential Fatty Acid Status & Immune Function in Parenteral Nutrition Patients
The purpose of this study is to determine if patients on long-term olive oil-based parenteral nutrition have an adequate essential fatty acid status and immune status, compared to age- and sex-matched healthy controls.
Patients, who suffer from severe chronic intestinal failure and whose nutritional intake cannot be met by oral food intake, have as their final option total parenteral nutrition, which contains all necessary macro- and micronutrients. Lipid emulsions are essential for these patients as they are a source of non glucose fuel calories, and they contain (essential) fatty acids which are important as structural component for many cells in the human body. Home parenteral nutrition patients are at risk for essential fatty acid deficiency. Data are lacking that indicate the optimal amount of essential fatty acids required for these patients. The latter seems especially relevant for patients receiving lipid prescriptions which are low in essential fatty acids, like ClinOleic®. Long-term parenteral nutrition dependent patients successfully use ClinOleic®. It is however unknown whether these patient remain to have an adequate essential fatty acid status in the long run. ;
Observational Model: Case Control, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04733066 -
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
|
||
Recruiting |
NCT05315765 -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recovery
|
||
Recruiting |
NCT04577456 -
Chyme Reinfusion for Type 2 Intestinal Failure
|
N/A | |
Recruiting |
NCT03590418 -
Microbial Diversity of Small Bowel Stoma Effluent and Colonic Faeces
|
||
Completed |
NCT05909228 -
Bone Markers in Pediatric IF
|
||
Recruiting |
NCT06283615 -
Effect of Vitamin D on Skeletal Muscle Function and Qol in Patients With Chronic Intestinal Failure/Insufficiency
|
N/A | |
Enrolling by invitation |
NCT06094504 -
Spectral Lighting and Intestinal Failure
|
N/A | |
Recruiting |
NCT05902104 -
CGM-Assisted Management of PN
|
||
Completed |
NCT01386034 -
Effects of Oral Citrulline on Protein Metabolism in Patients With Intestinal Failure (Citrugrêle 2)
|
Phase 3 | |
Recruiting |
NCT05868785 -
Effect of Nocturnal Parenteral Nutrition on Bone Turnover and Energy Metabolism
|
N/A | |
Terminated |
NCT01573286 -
Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00793195 -
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
|
Phase 2 | |
Recruiting |
NCT06169774 -
Video Training Supplementation for Patients Discharged on Home Parental Nutrition
|
N/A | |
Completed |
NCT03222232 -
Catheter Salvage in Intestinal Failure Patients
|
N/A | |
Completed |
NCT06391762 -
Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure
|
||
Completed |
NCT00995813 -
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
|
Phase 4 | |
Recruiting |
NCT05813535 -
8.4% Sodium Bicarbonate Locks in Intestinal Failure
|
Phase 2 | |
Completed |
NCT03869957 -
Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure
|
N/A | |
Completed |
NCT00286039 -
Plasma Citrulline Level in Relation to Absorptive Surface
|
N/A | |
Completed |
NCT01946503 -
Infant & Toddler Short Gut Feeding Outcomes Study
|